Capricor Therapeutics Ownership | Who Owns Capricor Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Capricor Therapeutics Ownership Summary

Capricor Therapeutics is owned by 29.93% institutional investors, 16.79% insiders, and 53.27% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 6.28% of CAPR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.64% of its assets in Capricor Therapeutics shares.

CAPR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Capricor Therapeutics	29.93%	16.79%	53.27%
Sector	Healthcare Stocks	492.67%	11.09%	-403.76%
Industry	Biotech Stocks	295.31%	11.22%	-206.53%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	2.87M	6.28%	$20.69M
Blackrock	1.63M	5.19%	$7.77M
Vanguard group	2.21M	4.83%	$15.91M
Geode capital management	961.57K	2.10%	$6.93M
State street	801.34K	1.75%	$5.78M
Morgan stanley	551.69K	1.21%	$3.98M
Pier capital	496.55K	1.09%	$3.58M
J. goldman & co lp	481.98K	1.05%	$3.48M
Dg capital management	470.33K	1.03%	$3.39M
National bank of canada /fi/	397.70K	0.87%	$2.87M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Dg capital management	470.33K	1.18%	$3.39M
Pier capital	496.55K	0.56%	$3.58M
Black diamond financial	277.74K	0.22%	$2.00M
Ikarian capital	264.64K	0.19%	$1.91M
Gsa capital partners llp	215.68K	0.13%	$1.55M
J. goldman & co lp	481.98K	0.09%	$3.48M
Ellerson group inc /adv	17.10K	0.08%	$123.29K
Sheets smith investment management	14.86K	0.07%	$107.16K
Quinn opportunity partners	128.34K	0.07%	$925.32K
Skopos labs	38.01K	0.03%	$274.07K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	1.63M	0.00%	1.25M
J. goldman & co lp	481.98K	0.09%	481.98K
Dg capital management	470.33K	1.18%	470.33K
Ikarian capital	264.64K	0.19%	264.64K
National bank of canada /fi/	397.70K	0.00%	229.00K

Top Sellers

Holder	Shares	% Assets	Change
Altium capital management lp	-	-	-714.00K
State street	801.34K	0.00%	-665.34K
Octagon capital advisors lp	-	-	-450.00K
Ubs group	124.72K	0.00%	-424.71K
Superstring capital management lp	-	-	-241.19K

New Positions

Holder	Shares	% Assets	Change	Value
J. goldman & co lp	481.98K	0.09%	481.98K	$3.48M
Dg capital management	470.33K	1.18%	470.33K	$3.39M
Ikarian capital	264.64K	0.19%	264.64K	$1.91M
Gsa capital partners llp	215.68K	0.13%	215.68K	$1.55M
Quinn opportunity partners	128.34K	0.07%	128.34K	$925.32K

Sold Out

Holder	Change
Aquatic capital management	-1.00
True wealth design	-5.00
Parallel advisors	-13.00
Northwestern mutual wealth management	-19.00
Eversource wealth advisors	-35.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	132	-7.04%	13,682,657	-27.15%	29	1.77%	63	-24.10%	40	37.93%
Mar 31, 2025	10	-92.48%	930,147	-94.63%	2	0.08%	7	-92.39%	2	-86.67%
Dec 31, 2024	40	-57.45%	6,498,502	-22.35%	19	3.07%	32	-42.86%	3	-72.73%
Sep 30, 2024	94	38.24%	8,369,327	30.24%	25	6.02%	56	33.33%	11	-26.67%
Jun 30, 2024	68	7.94%	6,426,234	33.35%	20	8.30%	42	-	15	66.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.21M	2.64%	-26.63K
iShares Russell 2000 ETF	928.19K	2.03%	-
Vanguard US Total Market Shares ETF	872.18K	1.91%	-
SPDR® S&P Biotech ETF	584.18K	1.28%	1.30K
Vanguard Institutional Extnd Mkt Idx Tr	457.38K	1.00%	-200.35K
Fidelity Small Cap Index	386.43K	0.85%	14.87K
iShares Russell 2000 Growth ETF	336.12K	0.74%	-
State St Russell Sm/Mid Cp® Indx NL Cl C	227.13K	0.50%	1.15K
State St Russell Sm/Mid Cp® Indx SL Cl I	227.13K	0.50%	-
Fidelity Extended Market Index	226.33K	0.50%	-1.86K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 20, 2024	Nippon Shinyaku Co Ltd	-	Buy	$15.00M
Oct 12, 2023	Musket David B	-	Buy	$1.13K
Oct 10, 2023	COLLIER EARL M JR	-	Buy	$28.30K
Oct 09, 2023	Musket David B	-	Buy	$14.33K
Oct 06, 2023	Auwaerter Paul Gisbert	-	Buy	$14.20K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	1	-
2024 Q2	-	-
2024 Q1	-	-

CAPR Ownership FAQ

Who Owns Capricor Therapeutics?

Capricor Therapeutics shareholders are primarily institutional investors at 29.93%, followed by 16.79% insiders and 53.28% retail investors. The average institutional ownership in Capricor Therapeutics's industry, Biotech Stocks , is 295.31%, which Capricor Therapeutics falls below.

Who owns the most shares of Capricor Therapeutics?

Capricor Therapeutics’s largest shareholders are Blackrock funding, inc. /de (2.87M shares, 6.28%), Blackrock (1.63M shares, 5.19%), and Vanguard group (2.21M shares, 4.83%). Together, they hold 16.30% of Capricor Therapeutics’s total shares outstanding.

Does Blackrock own Capricor Therapeutics?

Yes, BlackRock owns 5.19% of Capricor Therapeutics, totaling 1.63M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.77M$. In the last quarter, BlackRock increased its holdings by 1.25M shares, a 326.62% change.

Who is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested?

Dg capital management is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.18% of its assets in 470.33K Capricor Therapeutics shares, valued at 3.39M$.

Who is the top mutual fund holder of Capricor Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Capricor Therapeutics shares, with 2.64% of its total shares outstanding invested in 1.21M Capricor Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools